Seegakula Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bengaluru Rural, Karnataka, India, established in 2007.
2007 Bengaluru Rural, Karnataka, India Active
Last Updated:
Access Report
About Seegakula Pharmaceuticals Private Limited

Seegakula Pharmaceuticals Private Limited, a active private limited company, was established on 29 March 2007 in Bengaluru Rural, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KA2007PTC042292. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.47 M.

It upholds a compliant status. Employing 2 professional, Its leadership includes Seegakula Sathyanarayana Setty (Director), Manoj Nagaraj (Director), Hariharan Sakthivel (Director). Past directors included Manoj Nagaraj, Hariharan Sakthivel, Vijaya Kumar Kothamasu Reddappa. It holds ₹6.91 Cr open charges and ₹6.91 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No. 324, 1St Stage, Sompura Industrial Area, Sompura, Nelamangala Taluk,, Bengaluru Rural, Karnataka, 562132.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232KA2007PTC042292

  • Registration Number

    042292

  • Incorporation Date

    29 March 2007

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹9.47 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.47 M
  • Company Age 18 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 6.91 Cr
  • Satisfied Charges ₹ 6.91 Cr
  • Revenue Growth **** 113.08%
  • Profit Growth **** 11.03%
  • Ebitda **** 5.73%
  • Net Worth -291.33%
  • Total Assets -0.89%
Company report

Seegakula Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Seegakula Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Seegakula Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Seegakula Sathyanarayana Setty Director 29 Mar 2007 Current
Manoj Nagaraj Director 29 Jan 2018 Current
Hariharan Sakthivel Director 29 Jan 2018 Current
Sujatha Sathyanarayana Director 29 Mar 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Director 20 Feb 2010 Past
Pramod Abcsdd Director 25 Mar 2016 Past
Pramod Abcsdd Additional Director 11 Oct 2017 Past
Pramod Abcsdd Director 20 Nov 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Seegakula Pharmaceuticals.

Seegakula Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 113.08% increase. The company also saw a substantial improvement in profitability, with a 11.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 291.33%.

Seegakula Pharmaceuticals revenue growth over time
Seegakula Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 113.08%
*******
*******
*******
*******
Revenue from Operations
*******
 102.03%
*******
*******
*******
*******
Total Assets
*******
 -0.89%
*******
*******
*******
*******
Profit or Loss
*******
 11.03%
*******
*******
*******
*******
Net Worth
*******
 -291.33%
*******
*******
*******
*******
EBITDA
*******
 5.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Seegakula Pharmaceuticals?

In 2020, Seegakula Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹69,148,000.00

Satisfied Charges

₹69,148,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 6.91 Cr
Latest Charge Details
Date Lender Amount Status
29 Aug 2016 State Bank Of India ₹6.91 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Seegakula Pharmaceuticals?

Seegakula Pharmaceuticals has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Seegakula Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seegakula Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Seegakula Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 29 Aug 2016 via Charge ID 100050671 with State Bank Of India was fully satisfied on 06 May 2025. was completed.

  • Annual General Meeting

    The activity Seegakula Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Seegakula Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.

  • Charges

    A charge with State Bank Of India of Rs. 6.91 Cr registered on 29 Aug 2016 with Charge ID 100050671 was modified on 04 Jan 2022. was recorded as a recent event.

  • Director Appointment

    The activity Manoj Nagaraj was appointed as a Director was appointed as a Director on 29 Jan 2018 & has been associated with this company since 8 years 1 month . was completed.

  • Director Appointment

    Progress on Hariharan Sakthivel was appointed as a Director was appointed as a Director on 29 Jan 2018 & has been associated with this company since 8 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Seegakula Pharmaceuticals Private Limited?

The CIN of Seegakula Pharmaceuticals Private Limited is U24232KA2007PTC042292.

Where is Seegakula Pharmaceuticals Private Limited headquartered?

Seegakula Pharmaceuticals Private Limited is headquartered at Plot No. 324, 1St Stage, Sompura Industrial Area, Sompura, Nelamangala Taluk,, Bengaluru Rural, Karnataka, 562132.

When was Seegakula Pharmaceuticals Private Limited incorporated?

Seegakula Pharmaceuticals Private Limited was incorporated on 29 March 2007.

Who are the current directors of Seegakula Pharmaceuticals Private Limited?

The current directors of Seegakula Pharmaceuticals Private Limited are

What is the primary industry of Seegakula Pharmaceuticals Private Limited?

The primary industry of Seegakula Pharmaceuticals Private Limited is Manufacturing.

Is Seegakula Pharmaceuticals Private Limited a listed company?

Seegakula Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Seegakula Pharmaceuticals Private Limited?

The authorized capital of Seegakula Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.47 M.

What is the compliance status of Seegakula Pharmaceuticals Private Limited?

The compliance status of Seegakula Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available